Angiogenesis and hypertension

Journal of Hypertension

Volumn 16, Issue 11, 1998, Pages 1563-1572

  Le Noble, Ferdinand A C ^a   Stassen, Frank R M ^a   Hacking, Wim J G ^a   Struijker Boudier, Harry A J ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Angiogenesis; Essential hypertension; Microcirculation; Spontaneous hypertension; Vascular remodeling

Indexed keywords

ANGIOGENESIS; EMBRYO DEVELOPMENT; ESSENTIAL HYPERTENSION; MICROCIRCULATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0031766030     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816110-00001     Document Type: Review

References (103)

1. Folkman J. Clinical applications of research on angiogenesis. N Engl J Med 1995; 333:1757-1763.
2. Folkman J, Szabo S, Stovroff M, McNeil P, Li W, Shing Y. Duodenal ulcer: discovery of a new mechanism and development of angiogenic therapy which accelerates healing. Ann Surg 1991; 214:414-427.
3. Fujita M, Ohno A, Wada O, Miwa K, Nozawa T, Yamanishi K, et al. Collateral circulation as a marker of the presence of viable myocardium in patients with recent myocardial infarction. Am Heart J 1991; 122:409-414.
4. Schaper W, Ito WD. Molecular mechanisms of coronary collateral vessel growth. Circ Res 1996; 79:911-919.
5. Risau W. Mechanisms of angiogenesis. Nature 1997; 386:671-674.
6. Risau W, Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol 1995; 11:73-91.
7. Bergwerff M, De Ruiter MC, Poelmann RE, Gittenberger-de Groot AC. Onset of elastogenesis and downregulation of smooth muscle actin as distinguishing phenomena in artery differentiation in the chick embryo. Anat Embryol 1996; 194:545-557.
8. Hu J-S, Hastings GA, Cherry S, Gentz R, Ruben S, Coleman TA. A novel regulatory function of proteolytically cleaved VEGF-2 for vascular endothelial and smooth muscle cells. FASEB J 1997; 11:498-504.
9. Carmeliet P, Collen D. Genetic analysis of blood vessel formation. Role of endothelial versus smooth muscle cells. Trends Cardiovasc Med 1997; 7:271-281.
10. Joukov V, Pajusola K, Kaipanen A, Chilov D, Lahtinen I, Kukk E, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996; 15:290-298.
11. Davis S, Aldrich T, Jones PF, Acheson A, Compton DL, Jain V, et al. Isolation of angiopoietin-1, a ligand for the angiogenic TIE2 receptor, by secretion-trap expression cloning. Cell 1996; 87:1161-1169.
12. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, et al. Angiopoietin-2, a natural antagonist for TIE2 that disrupts in vivo angiogenesis. Science 1997; 277:55-60.
13. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996; 87:1171-1180.
14. Vikkula M, Boon LM, Carraway KL, Calvert JT, Diamonti AJ, Goumnerov B, et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 1996; 87:1181-1190.
15. Hirschi KK, D'Amore PA. Pericytes in the microvasculature. Cardiovasc Res 1996; 32:687-698.
16. De Ruiter MC, Hogers B, Poelmann RE, Van Iperen, L, Gittenberger-de Groot AC. The development of the vascular system in quail embryos: a combination of microvascular corrosion casts and immunohistochemical identification. Scanning Micr 1992; 5:1082-1090.
17. Campbell GR, Campbell JH. Development of the vessel wall: overview. In: Schwartz SM, Mecham RP (editors). The vascular smooth muscle cell. San Diego: Academic Press; 1995:1-17.
18. De Ruiter MC, Poelmann RE, Van Munsteren JC, Mironov V, Markwald RR, Gittenberger-de Groot AC. Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. Circ Res 1997; 80:444-451.
19. Gittenberger-de Groot AC, Slomp J, De Ruiter MC, Poelmann RE. Smooth muscle cell differentiation during early development and during intimal thickening formation in the ductus arteriosus. In: Schwartz SM, Mecham RP (editors): In: The vascular smooth muscle cell. San Diego: Academic Press, 1995:17-37.
20. Katoh Y, Periasamy M. Growth and differentiation of smooth muscle cells during vascular development. Trends Cardiovasc Med 1996; 6:100-106.
21. Daemen MJAP, De Mey JGR. Regional heterogeneity of arterial structural changes. Hypertension 1995; 25 (part 1):464-473.
22. Beck, INL, D'Amore PA. Vascular development: cellular and molecular regulation. FASEB J 1997; 11:365-373.
23. Le Noble FAC, Kessels-van Wylick LCGA, Hacking WJG, Slaaf DW, oude Egbrink MGA, Struijker Boudier HAJ. The role of angiotensin II and prostaglandins in arcade formation in a developing microvascular network. J Vasc Res 1996; 33:480-488.
24. Patan S, Haenni B, Burri PH. Implementation of intersusceptive microvascular growth in the chicken chorio-allantoic membrane. I. Pillar formation by folding of the capillary wall. Microvasc Res 1996; 51:80-98.
25. Pepper MS. Manipulating angiogenesis. From basic science to the bedside. Arterioscler Thromb Vasc Biol 1997; 17:605-619.
26. Wong AL, Haroon ZA, Werner S, Dewhirst MW, Greenberg CS, Peters KG. TIE2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ Res 1997; 81:567-574.
27. De Robertis EM, Oliver G, Wright CVE. Homeobox genes and the vertebrate body plan. Sci Am 1990; 263:26-32.
28. Blankesteijn WM, Essers-Janssen YPG, Verluyten MJA, Daemen MJAP, Smits JFM. A homologue of Drosophila tissue polarity gene frizzled is expressed in migrating myofibroblasts in the infarcted rat heart. Nat Med 1997; 3:541-544.
29. Ingber DE, Prusty D, Sun Z, Betensky H, Wang N. Cell shape, cytoskeletal mechanics, and cell cycle control in angiogenesis. J Biomechanics 1995; 28:1471-1484.
30. Hudlicka O, Brown M Egginton S. Angiogenesis in skeletal and cardiac muscle. Physiol Rev 1992; 72:369-417.
31. Reynolds LP, Killilea SD, Redmer DA. Angiogenesis in the female reproductive system FASEB J 1992; 6:886-892.
32. Ryan KJ, Makris A. Significance of angiogenic and growth factors in ovarian follicular development. Adv Exp Med Biol 1987; 219:203-209.
33. Kumar A, Lindner V. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler Thromb Vasc Biol 1997; 17:2238-2244.
34. Guyton JR, Hartley CJ. Flow restriction of one carotid artery in juvenile rats inhibits growth of arterial diameter. Am J Physiol 1985; 248:H540-H546.
35. Langille BI, O'Donnell F. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science 1986; 231:405-407.
36. Pourageaud F, De Mey JGR. Structural properties of rat mesenteric small arteries after 4-wk exposure to elevated or reduced blood flow. Am J Physiol 1997; 273:H1699-H1706.
37. Unthank JL, Fatrh SW, Burkhart HM, Miller SC, Dalsing MC. Wall remodeling during luminal expansion of mesenteric arterial collaterals in the rat. Circ Res 1996; 79:1015-1023.
38. Schiffers PMH, Fazzi GE, Van Ingen Schenau D, De Mey JGR. Effects of candidate autocrine and paracrine mediators on growth responses in isolated rat arteries. Arterioscler Thromb Vasc Biol 1994; 14:420-426.
39. Bardy N, Karillon GJ, Merval R, Samuel JL, Tedgui A. Differential effects of pressure and flow on DNA and protein synthesis and on fibronectin expression by arteries in a novel organ culture system. Circ Res 1995; 77:684-694.
40. Price RJ, Skalak TC. A circumferential stress growth rule predicts arcade arteriole formation in a network model. Microcirculation 1995; 2:41-51.
41. Struijker Boudier HAJ, Smits JFM, De Mey JGR. Pharmacology of cardiac and vascular remodeling. Annu Rev Pharmacol Toxicol 1995; 35:509-539.
42. Bardy N, Merval R, Benessiano J, Samuel JL, Tedgui A. Pressure and angiotensin II synergistically induce aortic fibronectin expression in organ culture model of rabbit aorta. Evidence for a pressure-induced tissue renin-angiotensin system. Circ Res 1996; 79:70-78.
43. Tronc F, Wassef M, Esposito B, Henrion D, Glagov S, Tedgui A. Role of NO in flow-induced remodeling of the rabbit common carotid artery. Arterioscler Thromb Vasc Biol 1996; 16:1256-1262.
44. Sage EH, Vernon RB. Regulation of angiogenesis by extracellular matrix: the growth and the glue. J Hypertens 1994; 12 (suppl 10):145-152.
45. Ingber DE. Extracellular matrix and cell shape: potential control points for inhibition of angiogenesis. J Cell Biochem 1991 ; 47:236-241.
46. Ingber DE. Integrins as mechanochemical transducers. Curr Opin Cell Biol 1991; 3:841-848.
47. Guyton AC, Granger JH, Coleman TG. Autoregulation of the total systemic circulation and its relation to control of cardiac output and arterial pressure. Circ Res 1971; 28 (suppl 1):93-97.
48. Struijker Boudier HAJ. Hemodynamics of experimental hypertension. In: Zanchetti A, Mancia G (editors): Handbook of hypertension. Amsterdam: Elsevier; 1997:170-213.
49. Folkow B. Physiological aspects of primary hypertension. Physiol Rev 1982; 62:347-504.
50. Conway J. Hemodynamic aspects of essential hypertension in humans. Physiol Rev 1984; 64:617-660.
51. Prewitt RL, Wang DH. The importance of differences in the pressure profile of the arteriolar bed. In: Mulvany MJ (editor): Resistance arteries: structure and function. Amsterdam: Excerpta Medica 1991:61-64.
52. Christensen KL, Mulvany MJ. Mesenteric arcade arteries contribute substantially to vascular resistance in conscious rats. J Vasc Res 1993; 30:73-79.
53. Pries AR, Secomb TW, Gaehtgens P. Biophysical aspects of blood flow in the microvasculature. Cardiovasc Res 1996; 32:654-667.
54. Greene AS, Tonellato PJ, Lui J, Lombard JH, Cowley AW. Microvascular rarefaction and tissue vascular resistance in hypertension. Am J Physiol 1989; 256:H126-H131.
55. Struijker Boudier HAJ, Le Noble JLML, Messing MWJ, Huijberts MSP, Le Noble FAC, Van Essen H. The microcirculation and hypertension. J Hypertens 1992; 10 (suppl 7):147-156.
56. Schmid-Schönbein GW, Chen S. The microcirculation in hypertension. In: Zanchetti A, Tarazi RC (editors): Handbook of hypertension, vol. 7, Pathophysiology of hypertension: cardiovascular aspects. Amsterdam: Elsevier Science Publishers 1986; 465-489.
57. Prewitt RL, Hashimoto H, Stacy DL. Structural and functional rarefaction of microvessels in hypertension. In: Lee R (editor): Blood vessel changes in hypertension: structure and function. Boca Raton, Florida: CRC Press; 1990:71-90.
58. Struijker Boudier HAJ, Crijns FRL, Stolte J, Van Essen H. Assessment of the microcirculation in cardiovascular disease. Clin Sci 1996; 91:131-139.
59. Bollinger A, Fagrell B (editors). Clinical capillaroscopy. Toronto: Hogrefe and Huber Publishers; 1990.
60. Le Noble JLML, Tangelder GJ, Slaaf DW, Van Essen H, Reneman RS, Struijker Boudier HAJ. A functional morphometric study of the cremaster muscle microcirculation in young spontaneously hypertensive rats. J Hypertens 1990; 8:741-748.
61. Sullivan JM, Prewitt RL, Josephs JA. Attenuation of the microcirculation in young patients with high-output borderline hypertension. Hypertension 1983; 5:844-851.
62. Noon JP, Walker BR, Webb DJ, Shore AC, Holton DW, Edwards HV, Watt GCM. Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest 1997; 99:1873-1879.
63. Struijker Boudier HAJ. Vascular growth and hypertension. In: Swales JD (editor): Textbook of hypertension, ch 10. Oxford: Blackwell Scientific Publishers; 1994:200-213.
64. Chapman N, Mohamudally A, Cerutti A, Stanton A, Sayer AA, Cooper C, et al. Retinal vascular network architecture in low-birth-weight men. J Hypertens 1997; 15: 1449-1453.
65. Murray CD. The physiological principle of minimum work. 1. The vascular system and the cost of blood volume. Proc Nat Acad Sci USA 1926; 12:207-214.
66. Law CM, Shiell AW. Is blood pressure inversely related to birth weight? The strength of evidence from a systematic review of the literature. J Hypertens 1996; 14:935-941.
67. Hutchins PM, Darnell AE. Observation ol a decreased number of small arterioles in spontaneously hypertensive rats. Circ Res 1974; 34/35 (suppl 1):161-165.
68. Hutchins PM, Lynch CD, Cooney PT, Curseen KA. The microcirculation in experimental hypertension and aging. Cardiovasc Res 1996; 32:772-780.
69. Thoma R. Untersuchungen über die Histogenesis und Histomechanik des Gefasssystems. Stuttgart: Enke, 1893.
70. Zamir M. Shear forces and blood vessel radii in the cardiovascular system. J Gen Physiol 1977; 69:449-461.
71. Koller A, Kaley G. Shear stress dependent regulation of vascular resistance in health and disease: role of endothelium. Endothelium 1996; 4:247-272.
72. Skalak TC, Price RJ. The role of mechanical stresses in microvascular remodeling. Microcirculation 1996; 3:143-165.
73. Hacking WJG, Van Bavel E, Spaan JAE. Shear stress is not sufficient to control growth of vascular networks: a model study Am J Physiol 1996; 270:H364-H375.
74. Prewitt RL, Chen H, Dowell R. Development of microvascular rarefaction in the spontaneously hypertensive rat. Am J Physiol 1982; 243:H243-H251.
75. Hansen-Smith FM, Morris LW, Gerene AS, Lombard JH, Rapid microvessel rarefaction with elevated salt intake and reduced renal mass hypertension in rats. Circ Res 1996; 79:324-330.
76. Moreau P, Tea B-S, Dam T-V, Hamet P. Altered balance between cell replication and apoptosis in hearts and kidneys of newborn SHR. Hypertension 1997; 30 (part 2):720-724.
77. Gobé G, Browning J, Howard T, Hogg N, Winterford C, Cross R. Apoptosis occurs in endothelial cells during hypertension induced microvascular rarefaction. J Struct Biol 1997; 118:63-72.
78. Rieder MJ, Roman RJ, Greene AS. Reversal of microvascular rarefaction and reduced renal mass hypertension. Hypertension 1997; 30 (part 1): 120-127.
79. Unger T, Chung O, Csikos T, Culman J, Gallinat S, Gohlke P, et al. Angiotensin receptors. J Hypertens 1996; 14 (suppl 5):95-103.
80. Hernandez I, Greene AS. Hemodynamic and microcirculatory changes during development of renal hypertension. Am J Physiol 1995; 268:H33-H38.
81. Dusseau JW, Hutchins PM. Hypoxia-induced angiogenesis in chick chorioallantoic membranes: a role for adenosine. Respir Physiol 1988; 71:33-44.
82. Jin RK, Schlenger K, Hockel M, Yuan F. Quantitative angiogenesis assays: progress and problems. Nat Med 1997; 3:1203-1208.
83. Schmid-Schönbein GW, Zweifach BW, Kovalcheck S. The application of stereological principles to morphometry of the microcirculation in different tissues. Microvasc Res 1977; 14:303-317.
84. Greenberg S, Gaines K, Sweatt D. Evidence for circulating factors as a cause of venous hypertrophy in spontaneously hypertensive rats. Am J Physiol 1981; 241:H421-H430.
85. Wright GL. The vascular sensitizing character of plasma from spontaneously hypertensive rats. Can J Physiol Pharmacol 1981; 59:1111-1116.
86. Schlüter H, Offers E, Bruggemann G, Van der Giet M, Tepel M, Nordhoff E, et al. Diadenosine phosphates and the physiological control of blood pressure. Nature 1994; 367:186-188.
87. Aguilar E, Rodriguez L, Bellido C, De la Fuente M, Pinilla L. Changes in growth hormone secretion in spontaneously hypertensive rats. Neuroendocrinology 1990; 52:337-341.
88. Lever AF, Harrap SB. Essential hypertension: a disorder of growth with origins in childhood? J Hypertens 1992; 10:101-120.
89. Hilbert P, Lindpaintner K, Beckmann J, Serikawa T, Soubrier F, Dulbay C, et al. Chromosomal mapping of two genetic loci associated with blood pressure regulation in hereditary hypertensive rats. Nature 1991; 353:521-529.
90. Kapuscinski M, Charchar F, Innes B, Mitchell GA, Norman TL, Harrap SB. Nerve growth factor gene and hypertension in spontaneously hypertensive rats. J Hypertens 1996; 14:191-197.
91. Rapp JP, Garrett MR, Deng AY. Construction of a double congenic strain to prove an epistatic interaction on blood pressure between rat chromosomes 2 and 10. J Clin Invest 1998; 101:1591-1595.
92. Barker DJP, Bull AR, Osmond C, Simmonds SJ. Fetal and placental size and risk of hypertension in adult life. BMJ 1990; 301:259-262.
93. Martyn CN, Barker DJP, Jespersen S, Greenwald S, Osmond C, Berry C. Growth in utero, adult blood pressure, and arterial compliance. Br Heart J 1995; 73:116-121.
94. Martyn CN, Greenwald SE. Impaired synthesis of elastin in walls of aorta and large conduit arteries during early development as an initiating event in pathogenesis of systemic hypertension. Lancet 1997; 350:953-955.
95. Berry CL, Looker T. An alteration in the chemical structure of the aortic wall induced by a finite period of growth inhibition. J Anal 1973; 114:83-94.
96. Berry CL. Hypertension and arterial development. Long-term considerations. Br Heart J 1978; 40:709-717.
97. Lindsay RS, Lindsay RM, Edwards CRW, Seckl JR. Inhibition of 11-beta-hydroxy-steroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring. Hypertension 1996; 27:1200-1204.
98. Crum R, Szabo S, Folkman J. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science 1985; 230:1375-1378.
99. Skov K, Mulvany MJ, Korsgaard N. Morphology of renal afferent arterioles in spontaneously hypertensive rats. Hypertension 1992; 20:821-827.
100. Norrelund H, Christensen KL, Samani NJ, Kimber P, Mulvany MJ, Korsgaard N. Early narrowed afferent arteriole is a contributor to the development of hypertension. Hypertension 1994; 24:301-308.
101. Hyink DP, Abrahamson DR. Origin of the glomerular vasculature in the developing kidney. Semin Nephrol 1995; 15:300-314.
102. Hinchcliffe SA, Lunch MRJ, Sargent PH, Howard CV, Van Velzen D. The effect of intra-uterine growth retardation on the development of renal nephrons. Br J Obstet Gynaecol 1992; 99:296-301.
103. Kitamoto Y, Tokunaga H, Tomita K. Vascular endothelial growth factor is an essential molecule for mouse kidney development: glomerulogenesis and nephrogenesis. J Clin Invest 1997; 99:2351-2357.